Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market in 2020. COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future. This report also analyses the impact of Coronavirus COVID-19 on the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) industry. Based on our recent survey, we have several different scenarios about the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market in terms of revenue. Players, stakeholders, and other participants in the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026. Regional and Country-level Analysis The report offers an exhaustive geographical analysis of the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026. Competition Analysis In the competitive analysis section of the report, leading as well as prominent players of the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market. The following players are covered in this report: Roche (Genentech) Amgen B-MS Merck Pfizer Novartis Eli Lilly and Company Johnson & Johnson GSK Sanofi Boehringer Ingelheim Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Type Aspirin Ibuprofen Naproxen Celecoxib Others Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Application Drug Store Hospital Pharmacies Online
This research study involves broad usage of both secondary and primary data sources. The research process involves the identification of numerous factors which affect the industry, comprising the market environment, government policy, historical data, present trends in the market, competitive landscape, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.
Market Estimation
Top-down and bottom-up approaches are used for validating the market size for companies, regional segments along with relevant market segmentations such as product type and application.
This report includes market estimations which are based on the marketed sale price of a product. Further breakdown of product segments, particular market share are formed based on the weightage assigned to every segment, which is derived of their usage rate and average price. The entire probable factors which effect the markets and influence them in a great way are included in this research report; and have been accounted for, studied in-depth and are confirmed through primary research. These are then studies to get the final qualitative and quantitative data. Any of the factors such as the outcome of inflation, economic downfall, and any kind of policy and regulatory alterations and/or other such factors are not accounted for in the market forecast. All of this data is amalgamated and included with thorough inputs and analysis from Gravitas Market Insights is curated in this report.
Along with the previously mentioned approaches, various data triangulation methods, in order to conduct market estimations and market forecasting for the complete market segments are detailed in this report. Key Companies present in the said market are also acknowledged via in-depth secondary research and primary research.
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue 1.4 Market Analysis by Type 1.4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Aspirin 1.4.3 Ibuprofen 1.4.4 Naproxen 1.4.5 Celecoxib 1.4.6 Others 1.5 Market by Application 1.5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2020 VS 2026 1.5.2 Drug Store 1.5.3 Hospital Pharmacies 1.5.4 Online 1.6 Coronavirus Disease 2019 (Covid-19): Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Impact 1.6.1 How the Covid-19 is Affecting the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry 1.6.1.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19?s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2015-2026) 2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Regions 2.2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Share by Regions (2015-2020) 2.2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter?s Five Forces Analysis 2.3.5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Strategy 2.3.6 Primary Interviews with Key Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Market Size 3.1.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue (2015-2020) 3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2015-2020) 3.1.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio 3.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2019 3.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Area Served 3.4 Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service 3.5 Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2015-2020) 4.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2021-2026) 5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Application (2015-2026) 5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) 5.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020) 6.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in North America (2019-2020) 6.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) 6.4 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) 7 Europe 7.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020) 7.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Europe (2019-2020) 7.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) 7.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) 8 China 8.1 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020) 8.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in China (2019-2020) 8.3 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) 8.4 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) 9 Japan 9.1 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020) 9.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Japan (2019-2020) 9.3 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) 9.4 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020) 10.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) 10.4 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) 11 India 11.1 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020) 11.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in India (2019-2020) 11.3 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) 11.4 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020) 12.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Central & South America (2019-2020) 12.3 Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) 12.4 Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Roche (Genentech) 13.1.1 Roche (Genentech) Company Details 13.1.2 Roche (Genentech) Business Overview and Its Total Revenue 13.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.1.4 Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)) 13.1.5 Roche (Genentech) Recent Development 13.2 Amgen 13.2.1 Amgen Company Details 13.2.2 Amgen Business Overview and Its Total Revenue 13.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.2.4 Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 13.2.5 Amgen Recent Development 13.3 B-MS 13.3.1 B-MS Company Details 13.3.2 B-MS Business Overview and Its Total Revenue 13.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.3.4 B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 13.3.5 B-MS Recent Development 13.4 Merck 13.4.1 Merck Company Details 13.4.2 Merck Business Overview and Its Total Revenue 13.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.4.4 Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 13.4.5 Merck Recent Development 13.5 Pfizer 13.5.1 Pfizer Company Details 13.5.2 Pfizer Business Overview and Its Total Revenue 13.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.5.4 Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 13.5.5 Pfizer Recent Development 13.6 Novartis 13.6.1 Novartis Company Details 13.6.2 Novartis Business Overview and Its Total Revenue 13.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.6.4 Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 13.6.5 Novartis Recent Development 13.7 Eli Lilly and Company 13.7.1 Eli Lilly and Company Company Details 13.7.2 Eli Lilly and Company Business Overview and Its Total Revenue 13.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.7.4 Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 13.7.5 Eli Lilly and Company Recent Development 13.8 Johnson & Johnson 13.8.1 Johnson & Johnson Company Details 13.8.2 Johnson & Johnson Business Overview and Its Total Revenue 13.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.8.4 Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 13.8.5 Johnson & Johnson Recent Development 13.9 GSK 13.9.1 GSK Company Details 13.9.2 GSK Business Overview and Its Total Revenue 13.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.9.4 GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 13.9.5 GSK Recent Development 13.10 Sanofi 13.10.1 Sanofi Company Details 13.10.2 Sanofi Business Overview and Its Total Revenue 13.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 13.10.4 Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 13.10.5 Sanofi Recent Development 13.11 Boehringer Ingelheim 10.11.1 Boehringer Ingelheim Company Details 10.11.2 Boehringer Ingelheim Business Overview and Its Total Revenue 10.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 10.11.4 Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 10.11.5 Boehringer Ingelheim Recent Development 13.12 Zhejiang Jiuzhou Pharmaceutical 10.12.1 Zhejiang Jiuzhou Pharmaceutical Company Details 10.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview and Its Total Revenue 10.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction 10.12.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) 10.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details
